Article
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Feb 2022
Park Hyunju, Shin Hyeong Chan, Yang Heera, Heo Jung, Ki Chang-Seok, Kim Hye Seung, Kim Jung-Han, Hahn Soo Yeon, Chung Yun Jae, Kim Sun Wook, Chung Jae Hoon, Oh Young Lyun, Kim Tae Hyuk
Abstract excerpt
Follicular thyroid carcinoma (FTC) has different clinicopathological characteristics than papillary thyroid carcinoma. However, there are no independent systems to predict cancer-specific survival (CSS) in FTC. Telomerase reverse transcriptase (TERT) promoter mutations are associated with tumor aggressiveness. Thus, it could be a potential prognostic marker. The aim of this study was to refine the CSS risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.